Prazosin is an alpha-blocker often used to help manage high blood pressure by relaxing blood vessels. It is also sometimes prescribed for other needs like certain symptoms related to PTSD. The recall affects specific lots in 1 mg, 2 mg, and 5 mg strengths, with expiration dates ranging into 2025 and 2026.
But here’s what matters most for you: not every bottle of blood pressure medication is involved, and not every person taking prazosin needs to panic. The FDA emphasizes that the risk from these low-level impurities is generally considered small, especially for short-term exposure. Still, the agency and manufacturers took action out of an abundance of caution to protect public health.
Why Do Nitrosamine Impurities Show Up in Medications?
Nitrosamines are a class of compounds that can occur naturally in some foods and water, but they become a bigger concern in pharmaceuticals when levels exceed strict safety limits set by the FDA. In this case, the specific impurity was N-nitroso prazosin impurity C.
Manufacturing processes, certain raw materials, or even how drugs are stored over time can sometimes lead to these trace amounts forming. This isn’t the first time the industry has seen nitrosamine-related recalls — similar issues have appeared in other blood pressure drugs in past years, prompting tighter quality controls across the board.
